Rivastigmine antagonizes deficits in prepulse inhibition induced by selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis

Neuroscience

Volumn 114, Issue 1, 2002, Pages 91-98

  Ballmaier, M ^a   Casamenti, F ^b   Scali, C ^b   Mazzoncini, R ^a   Zoli, M ^c   Pepeu, G ^b   Spano, P F ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Acetylcholinesterase inhibitor; Cholinergic basal forebrain; Immunotoxin; Psychosis; Sensorimotor gating

Indexed keywords

CHOLINE ACETYLTRANSFERASE; IMMUNOGLOBULIN G; RIVASTIGMINE; SAPORIN;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LOSS; CHOLINERGIC NERVE CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; GIANT CELL; IMMUNOCYTOCHEMISTRY; MALE; MICRODIALYSIS; NONHUMAN; OLIVARY NUCLEUS; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; STARTLE REFLEX; SYNAPSE; TASK PERFORMANCE; TELENCEPHALON;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANIMALS; ANTIBODIES, MONOCLONAL; BASAL NUCLEUS OF MEYNERT; CARBAMATES; CEREBRAL CORTEX; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC FIBERS; CHOLINESTERASE INHIBITORS; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; IMMUNOTOXINS; MALE; N-GLYCOSYL HYDROLASES; NEURAL INHIBITION; NEURAL PATHWAYS; NEURONS; PHENYLCARBAMATES; PSYCHOTIC DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; STARTLE REACTION; TREATMENT OUTCOME;

EID: 0037130594     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00234-8     Document Type: Article

References (48)

1. Arendt T., Bigl V., Arendt A., Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer disease. Ann. Neurol. 10:1983;499-505.
2. Bakshi V.P., Swerdlow N.R., Geyer M.A. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J. Pharmacol. Exp. Ther. 271:1994;787-794.
3. Ballard C., Piggott M., Johnson M., Cairns N., Perry R., McKeith I., Jaros E., O'Brien J., Holmes C., Perry E. Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Ann. Neurol. 48:2000;868-876.
4. Ballmaier M., Casamenti F., Zoli M., Pepeu G., Spano P.F. Selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis impairs prepulse inhibition of acoustic startle. Neuroscience. 108:2001;299-305.
5. Berger-Sweeney J., Heckers S., Mesulam M.M., Wiley R.G., Lappi D.A. Differential effects on spatial navigation of immunotoxin-induced cholinergic lesions of the medial septal area and nucleus basalis magnocellularis. J. Neurosci. 14:1994;4507-4519.
6. Bigl V., Woolf N.J., Butcher L.L. Cholinergic projections from the basal forebrain to frontal, temporal, occipital and cingulate cortices: a combined fluorescent and acetylcholinesterase analysis. Brain Res. Bull. 8:1982;727-750.
7. Bradford M.M. A rapid sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem. 72:1976;248-254.
8. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology. 156:2001;234-258.
9. Carlsson M., Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13:1990;272-276.
10. Felder C.C., Porter A.C., Skillman T.L., Zhang L., Bymaster J., Nathonson N.M., Hamilton S.E., Gomeza J., Wess J., McKinz E. Elucidating the role of muscarinic receptors in psychosis. Life Sci. 68:2001;2605-2613.
11. Fendt M., Liang L., Yeomans J.S. Brain stem circuits mediating prepulse inhibition of the startle reflex. Psychopharmacology. 156:2001;216-224.
12. Geyer M.A., Braff D. Startle habituation and sensorimotor gating in schizophrenia and related animal models. Schizophr. Bull. 13:1987;643-668.
13. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade of review. Psychopharmacology. 156:2001;117-154.
14. Geyer, M.A., Swerdlow, N.R., 1998. Measurement of startle response, prepulse inhibition, and habituation. In: Crawley, J.N., Skolnick, P., (Eds.), Current Protocols in Neuroscience. Wiley, New York, pp. 8.7.1-8.7.15.
15. Grace J., Daniel S., Stevens T., Shankar K.K., Walker Z., Byrne E.J., Butler S., Wolkinson D., Wollfor D., Waite J., McKeith J. Long-tem use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial. Int. Psychogeriatr. 13:2001;199-205.
16. Heimer L. Basal forebrain in the context of schizophrenia. Brain Res. Rev. 31:2000;205-235.
17. Heimer L., de Olmos J., Alheid G.F., Zaborszky L. 'Perestroika' in the basal forebrain: opening the border between neurology and psychiatry. Prog. Brain Res. 87:1991;109-165.
18. Jones C.K., Shannon H.E. Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex. J. Pharmacol. Exp. Ther. 294:2000;1017-1023.
19. Koch M., Kungel M., Herbert H. Cholinergic neurons in the pedunculopontine tegmental nucleus are involved in the mediation of prepulse inhibition of the acoustic startle reponse in rat. Exp. Brain Res. 97:1993;71-82.
20. Kumari V., Cotter P.A., Checkley S.A., Gray J.A. Effect of acute subcutaneous nicotine on prepulse inhibition of the acoustic startle reflex in healthy male non-smokers. Psychopharmacology. 132:1997;389-395.
21. Liberini P., Valerio A., Memo M., Spano P.F. Lewy-body dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer's disease? Trends Pharmacol. Sci. 17:1996;155-160.
22. Lysakowski A., Wainer B.H., Bruce G., Hersh L.B. An atlas of the regional and laminar distribution of choline acetyltransferase immunoreactivity in rat cerebral cortex. Neuroscience. 28:1989;291-336.
23. McGaughy J., Everitt B.J., Robbins T.W., Sarter M. The role of cholinergic afferent projections in cognition: impact of selective immunotoxins. Behav. Brain Res. 115:2000;251-263.
24. McGhie A., Chapman J. Disorders of attention and perception in schizophrenia. Br. J. Med. Psychol. 34:1961;102-116.
25. McKeith I., Del Ser T., Spano P.F., Emre M., Wesnes K., Anand R., Cicin-Sain A., Ferrara R., Spiegel R. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet. 356:2000;2031-2036.
26. Paxinos, G., Watson, C., 1982. The Rat Brain Stereotaxic Coordinates. Academic, New York.
27. Perry E.K., Lee M.L., Martin-Ruiz C.M., Court J.A., Volsen S.G., Merrit J., Folly E., Iversen P.E., Bauman M.L., Perry R.H., Wenk G.L. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am. J. Psych. 158:2001;1058-1066.
28. Pizzo D.P., Waite J.J., Thal L.J., Winkler J. Intraparenchymal infusions of 192 IgG-saporin: development of a method for selective and discrete lesioning of cholinergic basal forebrain nuclei. J. Neurosci. Methods. 91:1999;9-19.
29. Sarter M., Bruno J.P. Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders. Trends Neurosci. 22:1999;67-74.
30. Sarter M., Bruno J.P., Turchi J. Basal forebrain afferent projections modulating cortical acetylcholine, attention, and implication for neuropsychiatric disorders. Ann. N.Y. Acad. Sci. 29:1994;368-382.
31. Scali C., Giovannini M.G., Bartolini L., Prosperi C., Hinz V., Schmidt B., Pepeu G. Effect of metrifonate on extracellular brain acetylcholine and object recognition in old rats. Eur. J. Pharmacol. 352:1997;173-180.
32. Scali C., Prosperi C., Vannucchi M.G., Pepeu G., Casamenti F. Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: implication in Alzheimer's disease. Eur. J. Neurosci. 12:2000;1900-1912.
33. Sharp F.R., Tomitaka M., Bernaudin M., Tomitaka S. Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia? Trends Neurosci. 24:2001;330-334.
34. Steriade, M., Buzsaki, G., 1990. Parallel activation of thalamic and cortical neurons by brainstem and basal forebrain cholinergic systems. In: Steriade, M., Biesold, D. (Eds.), Brain Cholinergic Systems. Oxford University Press, New York, pp. 1-52.
35. Steriade M., Parent D., Pare D., Smith Y. Cholinergic and non-cholinergic neurons of cat basal forebrain project to reticular and mediodorsal thalamic nuclei. Brain Res. 408:1987;372-376.
36. Swerdlow N.R., Braff D.L., Geyer M.A. Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav. Pharmacol. 111:2000;185-204.
37. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch. Gen. Psych. 51:1994;139-154.
38. Swerdlow N.R., Caine S.B., Braff D.L., Geyer M.A. Neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications. J. Psychopharmacol. 6:1992;176-190.
39. Swerdlow N.R., Geyer M.A. Prepulse inhibition of acoustic startle in rats after lesions of the peduncolopontine tegmental nucleus. Behav. Neurosci. 107:1993;104-117.
40. Swerdlow N.R., Geyer M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments in schizophrenia. Schizophr. Bull. 24:1998;285-301.
41. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology. 156:2001;194-215.
42. Wainer, B.H., Mesulam, M.M., 1990. Ascending cholinergic pathways in the rat brain. In: Steriade, M., Biesold, D. (Eds.), Brain Cholinergic Systems. Oxford University Press, New York, pp. 65-119.
43. Wang R.H., Bejar C., Weinstock M. Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats. Neuropharmacology. 39:2000;497-506.
44. Webster J., Grossberg G.T. Late-life onset of psychotic symptoms. Am. J. Geriatr. Psych. 6:1998;196-202.
45. Wenk G.L. The nucleus basalis magnocellularis cholinergic system: one hundred years of progress. Neurobiol. Learn. Mem. 67:1997;214-227.
46. White K.E., Cummings J.L. Schizophrenia and Alzheimer's disease: clinical and pathophysiologic analogies. Compr. Psych. 37:1996;188-195.
47. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., DeLong M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1982;1237-1239.
48. Wu M., Jenden D.J., Fairchild M.D., Siegel J.M. Cholinergic mechanisms in startle and prepulse inhibition of the false cholinergic precursor N-aminodeanol. Behav. Neurosci. 107:1993;306-316.